Ignite Creation Date:
2024-05-05 @ 11:21 AM
Last Modification Date:
2024-10-26 @ 9:04 AM
Study NCT ID:
NCT00004688
Status:
COMPLETED
Last Update Posted:
2015-03-25
First Post:
2000-02-24
Brief Title:
Phase II Study of Carmustine Streptozocin and Mercaptopurine for Refractory or Recurrent Brain Neoplasms
Sponsor:
Emory University
Organization:
FDA Office of Orphan Products Development
Organization Data
Organization:
FDA Office of Orphan Products Development
Class:
FED
Study ID:
19913310
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Emory University
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None